Wound Care - Ireland

Ireland

Highlights

In Ireland, the revenue generated in the Wound Care market market in 2024 amounted to US$19.86m.
It is projected that the market will experience an annual growth rate of 0.58% (CAGR 2024-2029).
When comparing in Ireland to other countries globally, the United States generates the highest revenue in the Wound Care market market, with a total of US$1.05bn in 2024.
In terms of per person revenues, in Ireland, each individual contributed US$3.90 to the total revenue in 2024.
Ireland has seen a rise in demand for advanced wound care products due to its aging population and increasing prevalence of chronic diseases.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Wound Care market in Ireland is experiencing significant growth due to several factors. Customer preferences for advanced wound care products, increasing prevalence of chronic wounds, and a growing aging population are driving the demand for wound care products in the country.Customer preferences in Ireland are shifting towards advanced wound care products that offer better healing outcomes and improved patient comfort. This trend is in line with the global market, where customers are increasingly seeking innovative wound care solutions. The demand for advanced wound dressings, such as hydrocolloids, foams, and films, is on the rise in Ireland as they provide better moisture management and promote faster healing.The prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, is increasing in Ireland. This can be attributed to factors such as the rising incidence of diabetes and an aging population. Chronic wounds require specialized wound care products and treatments to promote healing and prevent complications. As a result, the demand for wound care products, including wound dressings, wound care devices, and wound healing agents, is growing in the country.Ireland has a growing aging population, which is also contributing to the growth of the wound care market. Elderly individuals are more prone to developing chronic wounds and require specialized wound care products to manage their conditions. The increasing number of elderly individuals in Ireland is driving the demand for wound care products and services.In addition to customer preferences and demographics, there are also local special circumstances that are influencing the growth of the wound care market in Ireland. The country has a well-developed healthcare infrastructure and a strong focus on healthcare innovation. This enables the adoption of advanced wound care technologies and products in the country. Furthermore, Ireland is home to several wound care companies and research institutions, which contribute to the development of new and innovative wound care products.Underlying macroeconomic factors, such as the overall economic growth and healthcare expenditure, also play a role in the development of the wound care market in Ireland. A growing economy and increased healthcare spending support the demand for wound care products and services. Additionally, favorable reimbursement policies and government initiatives aimed at improving wound care management further contribute to the growth of the market.Overall, the Wound Care market in Ireland is experiencing growth driven by customer preferences for advanced wound care products, increasing prevalence of chronic wounds, a growing aging population, local special circumstances, and underlying macroeconomic factors. As the demand for wound care products continues to rise, there are opportunities for both domestic and international companies to expand their presence in the Irish market.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.